Position in DXCM
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,735
+$455 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#856
of 964 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $18,984 across 2 Medical Devices names. DXCM ranks #2 (35.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
135 | $12,249 | |
| 2 | DXCM |
Dexcom Inc
This page
|
100 | $6,735 |
All Filings in DXCM
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,735 | 100 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $6,280 | 100 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $6,637 | 100 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,729 | 100 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $8,729 | 100 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,829 | 100 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $7,777 | 100 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $6,704 | 100 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $11,338 | 100 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $13,870 | 100 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $12,409 | 100 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $9,330 | 100 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $12,851 | 100 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $11,618 | 100 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $11,324 | 100 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $8,054 | 100 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $7,453 | 100 | Shares | Sole | 2022-07-19 | |
| No filing history on record for this holder in this stock. | ||||||